Avalon GloboCare (ALBT)
Nasdaq Market Closed
Avalon GloboCare is a small-cap technology and consumer health company that develops and commercialises products aimed at emerging health, wellness, and digital content markets. The business combines consumer-facing health technology with artificial intelligence applications, giving ALBT exposure to two areas where companies are seeking more automated, data-driven products and services.
Its consumer health technology activities include distribution of the Keto Air breathalyzer in North America. The device is marketed as a non-invasive way for consumers to measure ketosis levels, making it relevant to users following ketogenic diets or monitoring nutrition-related wellness goals. This segment places Avalon GloboCare in the broader market for at-home health and lifestyle monitoring tools, where ease of use and consumer adoption are key considerations.
The company also operates in artificial intelligence content technology. Through its AI-focused subsidiary, Avalon GloboCare works on systems for automated short-form video generation, enterprise documentation, and workflow automation. These tools are designed to help businesses create content, streamline internal processes, and reduce manual work through generative and automation technologies. The AI segment reflects a shift toward software-enabled products that can be sold into business and digital media use cases.
Avalon GloboCare’s profile differs from larger healthcare or software companies because it spans early-stage commercial opportunities rather than one mature operating vertical. For investors, ALBT is tied to execution risk, product adoption, and the company’s ability to turn its consumer health and AI platforms into sustainable revenue streams. Its shares are therefore most closely associated with speculative growth themes in wellness technology and applied artificial intelligence.
Last updated
- Market Cap
- 4.46M
- P/E
- —
- P/FCF
- —
- P/S
- 6.36
- Enterprise Value
- 3.8M
- Sector
- Industrials
- Industry
- Computer Programming Services
- Address
- 4400 ROUTE 9, FREEHOLD, NJ, 07728
Bronstein, Gewirtz & Grossman LLC Urges Concorde International Group, Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
Avalon GloboCare Announces Closing of up to $9.75 Million Private Placement Priced At-the-Market under Nasdaq Rules
Avalon GloboCare Announces up to $9.75 Million Private Placement Priced At-the-Market under Nasdaq Rules
Avalon GloboCare Reports Q3 2025 Progress with KetoAir™, Holistic Health Initiatives, and International Expansion
Avalon GloboCare to Launch Online Sales of KetoAir Breathalyzer in the United Kingdom
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALBT, NDOI, RDFN on Behalf of Shareholders
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – ALBT, NDOI, DNB, RSLS
Avalon GloboCare Launches “BrAce for Impact" Affiliate Marketing Program for the KetoAir Breathalyzer Device
Avalon GloboCare and Qi Diagnostics Enter into Memorandum of Understanding for Proposed Co-Development of Real-Time Cannabis Breathalyzer for Detecting Potential Impaired Driving
Avalon GloboCare Receives Notice from Nasdaq Regarding Delayed Quarterly Report
Avalon GloboCare Engages ChtrBx, a Marketing and Branding Company, to Launch KetoAir in the US
Avalon’s Laboratory Services MSO Acquires California-Based Medical Supply Company and Proprietary FDA-Registered External Male Catheter Device
Avalon’s Laboratory Services MSO Launches Innovative Laboratory Test for Tuberculosis
Avalon GloboCare’s Laboratory Services MSO Signs Exclusive In-Network Lab Services Agreement Providing Significant Expansion Opportunity into 21 States
Avalon GloboCare Provides Update on New Commercial Strategy
Avalon GloboCare Signs Agreement with Qi Diagnostics to Exclusively Distribute KetoAir Breathalyzer Device and AI-Enabled Software in North America, South America, U.K. and European Union
Avalon GloboCare Announces Issuance of Key U.S. Patent for Multiple Novel QTY-Code Modified Cytokine and Chemokine Protein Receptor Molecules
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 4.46M
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 3.8M
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- 0.38
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 6.36
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- -0.63
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 5.42
- EPS
- -1.51
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- —
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- —
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- —
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- -155.17%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -111.99%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.01
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 0.38
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 0.38
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.17
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 304.93K
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 0.37
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | — | — | 350.1K | 350.41K | — |
| Gross profit | — | — | 350.1K | 350.41K | — |
| Operating income | -2.72M | — | -76.19K | -3.89M | -2.18M |
| EBITDA | -2.16M | -38.65K | -31.86K | -3.84M | -2.18M |
| Net income | -4.48M | — | -254.27K | -13.46M | -2.32M |
| Basic EPS | -0.5 | — | -0.06 | -6.22 | -1.43 |
| Diluted EPS | -0.5 | — | -0.06 | -6.22 | -1.43 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 16.25M | 23.4M | 9.13M | 7.99M | 10.61M |
| Total liabilities | 4.52M | 14.17M | 13.62M | 15.1M | 14.5M |
| Total equity | 11.72M | 9.23M | -4.49M | -7.11M | -3.89M |
| Cash & equivalents | 776K | 109.09K | 333.93K | 201.53K | 1.37M |
| Current assets | 1.67M | 1.5M | 2.09M | 933.09K | 2.79M |
| Current liabilities | 4.44M | 8.11M | 13.6M | 15.07M | 14.45M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | -3.09M | -192.06K | -1.36M | -1.23M | -1.91M |
| Investing cash flow | 280.5K | 330.39K | 657.64K | 0 | 100.47K |
| Financing cash flow | 3.44M | 287.95K | 835.24K | 57.66K | 219.97K |
| Change in cash | 666.9K | -26.71K | 132.4K | -1.17M | -1.59M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | SCHEDULE 13G — Avalon GloboCare Corp. | View Filing | |
| edgar index | 10-Q — Avalon GloboCare Corp. | View Filing | |
| edgar index | 8-K — Avalon GloboCare Corp. | View Filing | |
| edgar index | 8-K/A — Avalon GloboCare Corp. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 424B3 — Avalon GloboCare Corp. | View Filing | |
| edgar index | EFFECT — Avalon GloboCare Corp. | View Filing | |
| edgar index | 8-K — Avalon GloboCare Corp. | View Filing | |
| edgar index | DEF 14A — Avalon GloboCare Corp. | View Filing | |
| edgar index | DEFA14A — Avalon GloboCare Corp. | View Filing | |
| edgar index | ARS — Avalon GloboCare Corp. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | CORRESP — Avalon GloboCare Corp. | View Filing | |
| edgar index | UPLOAD — Avalon GloboCare Corp. | View Filing | |
| edgar index | RW — Avalon GloboCare Corp. | View Filing | |
| edgar index | S-1 — Avalon GloboCare Corp. | View Filing | |
| edgar index | 8-K — Avalon GloboCare Corp. | View Filing | |
| edgar index | PRE 14A — Avalon GloboCare Corp. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Avalon GloboCare Corp. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 10-K — Avalon GloboCare Corp. | View Filing | |
| edgar index | 8-K — Avalon GloboCare Corp. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K/A — Avalon GloboCare Corp. | View Filing | |
| edgar index | D — Avalon GloboCare Corp. | View Filing | |
| edgar index | 8-K — Avalon GloboCare Corp. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SCHEDULE 13G — Avalon GloboCare Corp. | View Filing | |
| edgar index | 8-K — Avalon GloboCare Corp. | View Filing | |
| edgar index | DEF 14A — Avalon GloboCare Corp. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Avalon GloboCare Corp. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Avalon GloboCare Corp. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 3 — Avalon GloboCare Corp. | View Filing | |
| edgar index | 4 — Avalon GloboCare Corp. | View Filing | |
| edgar index | 8-K — Avalon GloboCare Corp. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Avalon GloboCare Corp. | View Filing | |
| edgar index | PRE 14A — Avalon GloboCare Corp. | View Filing | |
| edgar index | 8-K — Avalon GloboCare Corp. | View Filing | |
| edgar index | RW — Avalon GloboCare Corp. | View Filing | |
| edgar index | 8-K — Avalon GloboCare Corp. | View Filing | |
| edgar index | 8-K — Avalon GloboCare Corp. | View Filing | |
| edgar index | 8-K — Avalon GloboCare Corp. | View Filing | |
| edgar index | 8-K — Avalon GloboCare Corp. | View Filing | |
| edgar index | 8-K — Avalon GloboCare Corp. | View Filing | |
| edgar index | 8-K — Avalon GloboCare Corp. | View Filing | |
| edgar index | 8-K — Avalon GloboCare Corp. | View Filing | |
| form 4 | Form 4 — Mathews Michael | View Filing | |
| edgar index | 8-K — Avalon GloboCare Corp. | View Filing | |
| edgar index | 8-K — Avalon GloboCare Corp. | View Filing | |
| edgar index | DEF 14A — Avalon GloboCare Corp. | View Filing | |
| edgar index | 10-Q — Avalon GloboCare Corp. | View Filing | |
| edgar index | 8-K — Avalon GloboCare Corp. | View Filing | |
| edgar index | 425 — Avalon GloboCare Corp. | View Filing | |
| edgar index | 8-K/A — Avalon GloboCare Corp. | View Filing | |
| edgar index | 8-K — Avalon GloboCare Corp. | View Filing | |
| edgar index | 10-Q — Avalon GloboCare Corp. | View Filing | |
| edgar index | 8-K — Avalon GloboCare Corp. | View Filing | |
| edgar index | 425 — Avalon GloboCare Corp. | View Filing | |
| edgar index | 425 — Avalon GloboCare Corp. | View Filing | |
| edgar index | 425 — Avalon GloboCare Corp. | View Filing | |
| edgar index | 8-K — Avalon GloboCare Corp. | View Filing | |
| edgar index | 8-K — Avalon GloboCare Corp. | View Filing | |
| edgar index | 8-K — Avalon GloboCare Corp. | View Filing | |
| edgar index | 8-K — Avalon GloboCare Corp. | View Filing | |
| edgar index | 8-K — Avalon GloboCare Corp. | View Filing | |
| edgar index | 8-K — Avalon GloboCare Corp. | View Filing | |
| edgar index | 8-K — Avalon GloboCare Corp. | View Filing | |
| edgar index | 8-K — Avalon GloboCare Corp. | View Filing | |
| edgar index | S-3 — Avalon GloboCare Corp. | View Filing | |
| edgar index | S-4/A — Avalon GloboCare Corp. | View Filing |